A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma
- PMID: 33432837
- DOI: 10.2217/fon-2020-1113
A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma
Abstract
Aims: To elucidate the association between ferroptosis-related genes and prognosis in patients with lung adenocarcinoma (LUAD). Materials & methods: A ferroptosis-related gene signature was made by lasso regression analysis through the LUAD datasets of the Cancer Genome Atlas. The prognostic value of the multigene signature was externally validated in the GSE72094 dataset from the Gene Expression Omnibus database. Gene ontology and Kyoto Encyclopedia of Genes and Genomes analysis were used to explore underlying mechanisms. Results & conclusion: We established a novel ferroptosis-related gene signature for overall survival in LUAD that was predictive in both the training and validation cohorts. Immune-related pathways were significantly enriched, and immune status differed between the high- and low-risk groups. Targeting ferroptosis is a potential therapeutic option in LUAD. These results still need to be confirmed by more studies.
Keywords: TCGA; bioinformatics; ferroptosis; lung adenocarcinoma; signature; survival.
Plain language summary
Lay abstract Lung adenocarcinoma (LUAD) is a common type of lung cancer, a major contributor to cancer-related death in men and women worldwide. Ferroptosis is a form of regulated cell death that is dependent on iron. The relationship between ferroptosis-related gene expression and survival in patients with LUAD remains to be elucidated. In this article, the public datasets the Cancer Genome Atlas and the Gene Expression Omnibus were used to create a model with 12 ferroptosis genes to separate LUAD patients into high- and low-risk groups. The low-risk group had better survival than the high-risk group. We also found that the immune status was different in high-risk and low-risk patients. In conclusion, our study established a novel ferroptosis-related gene signature for survival in LUAD. The underlying mechanisms involve tumor immunity.
Similar articles
-
Exploring exosome data to identify prognostic gene signatures for lung adenocarcinoma.Future Oncol. 2021 Dec;17(34):4745-4756. doi: 10.2217/fon-2021-0261. Epub 2021 Oct 18. Future Oncol. 2021. PMID: 34658257
-
Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.FEBS Open Bio. 2021 Nov;11(11):3005-3018. doi: 10.1002/2211-5463.13288. Epub 2021 Oct 16. FEBS Open Bio. 2021. PMID: 34499810 Free PMC article.
-
A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma.Aging (Albany NY). 2021 Jun 11;13(12):16144-16164. doi: 10.18632/aging.203140. Epub 2021 Jun 11. Aging (Albany NY). 2021. PMID: 34115610 Free PMC article.
-
Regulation of Ferroptosis in Lung Adenocarcinoma.Int J Mol Sci. 2023 Sep 27;24(19):14614. doi: 10.3390/ijms241914614. Int J Mol Sci. 2023. PMID: 37834062 Free PMC article. Review.
-
Development of fatty acid metabolism-related models in lung adenocarcinomaA Review.Medicine (Baltimore). 2023 Jan 6;102(1):e32542. doi: 10.1097/MD.0000000000032542. Medicine (Baltimore). 2023. PMID: 36607846 Free PMC article. Review.
Cited by
-
Establishment of a Prognostic Model of Lung Adenocarcinoma Based on Tumor Heterogeneity.Front Mol Biosci. 2022 Apr 11;9:807497. doi: 10.3389/fmolb.2022.807497. eCollection 2022. Front Mol Biosci. 2022. PMID: 35480896 Free PMC article.
-
Harnessing ferroptosis for enhanced sarcoma treatment: mechanisms, progress and prospects.Exp Hematol Oncol. 2024 Mar 12;13(1):31. doi: 10.1186/s40164-024-00498-3. Exp Hematol Oncol. 2024. PMID: 38475936 Free PMC article. Review.
-
Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer.Front Cell Dev Biol. 2021 Oct 29;9:666025. doi: 10.3389/fcell.2021.666025. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34778244 Free PMC article.
-
An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients.Front Oncol. 2021 Jun 24;11:711776. doi: 10.3389/fonc.2021.711776. eCollection 2021. Front Oncol. 2021. PMID: 34249766 Free PMC article.
-
Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma.Cancer Cell Int. 2023 Sep 27;23(1):218. doi: 10.1186/s12935-023-03065-8. Cancer Cell Int. 2023. PMID: 37759294 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical